Latest UpdateJune 22, 2025 - New variant information availableLearn More →
Variant of Concern - High Transmissibility

Omicron BA.5 Variant

Comprehensive medical information about the Omicron BA.5 COVID-19 variant, including symptoms, transmission characteristics, and protection strategies.

Last updated: June 20, 2025

Transmissibility

Very High

4-5x more transmissible than original strain

Severity

Moderate

Generally milder than Delta variant

Immune Evasion

High

Can partially evade vaccine immunity

Vaccine Effectiveness

Good with Boosters

70-85% protection against severe illness

Common Symptoms

Most frequently reported symptoms for Omicron BA.5

Fever or Chills
Prevalence:78%
Common
Fatigue
Prevalence:85%
Very Common
Sore Throat
Prevalence:82%
Very Common
Runny Nose
Prevalence:75%
Common
Cough
Prevalence:68%
Common
Headache
Prevalence:71%
Common
Body Aches
Prevalence:64%
Common
Loss of Taste/Smell
Prevalence:23%
Less Common

Protection Strategies

Evidence-based measures to protect against Omicron BA.5

Vaccination + Boosters

85% effective

Updated vaccines provide strong protection against severe illness

N95/KN95 Masks

95% effective

High-quality masks significantly reduce transmission risk

Physical Distancing

70% effective

Maintaining 6+ feet distance reduces exposure risk

Good Ventilation

60% effective

Improved airflow reduces airborne transmission

Clinical Characteristics

Incubation Period

2-4 days

Shorter than previous variants

Infectious Period

5-10 days

Peak infectiousness 1-2 days before symptoms

Hospitalization Rate

2.3%

Lower than Delta (4.1%)

Reinfection Risk

23%

Higher than previous variants

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice. Always consult with healthcare professionals for personalized medical guidance. If you experience severe symptoms, seek immediate medical attention.